Targeted inhibition of SCFSKP2 confers anti-tumor activities resulting in a survival benefit in osteosarcoma

Jichuan Wang(Albert Einstein College of Medicine), Bang H. Hoang(Albert Einstein College of Medicine)
Oncogene
February 14, 2024
Cited by 20


Related Papers